Literature DB >> 23168988

Training a sophisticated microsurgical technique: interposition of external jugular vein graft in the common carotid artery in rats.

Karina Schleimer1, Jochen Grommes, Andreas Greiner, Houman Jalaie, Johannes Kalder, Stephan Langer, Thomas A Koeppel, Michael Jacobs, Maria Kokozidou.   

Abstract

Neointimal hyperplasia is one the primary causes of stenosis in arterialized veins that are of great importance in arterial coronary bypass surgery, in peripheral arterial bypass surgery as well as in arteriovenous fistulas.(1-5) The experimental procedure of vein graft interposition in the common carotid artery by using the cuff-technique has been applied in several research projects to examine the aetiology of neointimal hyperplasia and therapeutic options to address it. (6-8) The cuff prevents vessel anastomotic remodeling and induces turbulence within the graft and thereby the development of neointimal hyperplasia. Using the superior caval vein graft is an established small-animal model for venous arterialization experiment.(9-11) This current protocol refers to an established jugular vein graft interposition technique first described by Zou et al., (9) as well as others.(12-14) Nevertheless, these cited small animal protocols are complicated. To simplify the procedure and to minimize the number of experimental animals needed, a detailed operation protocol by video training is presented. This video should help the novice surgeon to learn both the cuff-technique and the vein graft interposition. Hereby, the right external jugular vein was grafted in cuff-technique in the common carotid artery of 21 female Sprague Dawley rats categorized in three equal groups that were sacrificed on day 21, 42 and 84, respectively. Notably, no donor animals were needed, because auto-transplantations were performed. The survival rate was 100 % at the time point of sacrifice. In addition, the graft patency rate was 60 % for the first 10 operated animals and 82 % for the remaining 11 animals. The blood flow at the time of sacrifice was 8±3 ml/min. In conclusion, this surgical protocol considerably simplifies, optimizes and standardizes this complicated procedure. It gives novice surgeons easy, step-by-step instruction, explaining possible pitfalls, thereby helping them to gain expertise fast and avoid useless sacrifice of experimental animals.

Entities:  

Mesh:

Year:  2012        PMID: 23168988      PMCID: PMC3520580          DOI: 10.3791/4124

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  15 in total

1.  Gene transfer of a broad spectrum CC-chemokine inhibitor reduces vein graft atherosclerosis in apolipoprotein E-knockout mice.

Authors:  Ziad A Ali; Christina A Bursill; Yanhua Hu; Robin P Choudhury; Qingbo Xu; David R Greaves; Keith M Channon
Journal:  Circulation       Date:  2005-08-30       Impact factor: 29.690

2.  Small interfering RNA to c-myc inhibits vein graft restenosis in a rat vein graft model.

Authors:  Jun Wang; Kun Liu; Li Shen; Haiwei Wu; Hua Jing
Journal:  J Surg Res       Date:  2011-04-20       Impact factor: 2.192

Review 3.  Why don't fistulas mature?

Authors:  B S Dixon
Journal:  Kidney Int       Date:  2006-08-02       Impact factor: 10.612

4.  Perivascular treatment with azathioprine reduces neointimal hyperplasia in experimental vein grafts.

Authors:  Thomas Schachner; Simone Heiss; Daniel Zipponi; Alexandar Tzankov; Oliver Bernecker; Arthur Kroell; Günther Laufer; Johannes Bonatti
Journal:  Heart Surg Forum       Date:  2006       Impact factor: 0.676

Review 5.  Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention.

Authors:  J G Motwani; E J Topol
Journal:  Circulation       Date:  1998-03-10       Impact factor: 29.690

6.  Rapamycin treatment is associated with an increased apoptosis rate in experimental vein grafts.

Authors:  Thomas Schachner; Alexander Oberhuber; Yping Zou; Alexandar Tzankov; Harald Ott; Günther Laufer; Johannes Bonatti
Journal:  Eur J Cardiothorac Surg       Date:  2005-02       Impact factor: 4.191

7.  Effect of matrix metalloproteinase-9 knockout on vein graft remodelling in mice.

Authors:  Anita C Thomas; Andrew C Newby
Journal:  J Vasc Res       Date:  2009-12-16       Impact factor: 1.934

8.  Mouse model of venous bypass graft arteriosclerosis.

Authors:  Y Zou; H Dietrich; Y Hu; B Metzler; G Wick; Q Xu
Journal:  Am J Pathol       Date:  1998-10       Impact factor: 4.307

9.  Perivascular application of C-type natriuretic peptide attenuates neointimal hyperplasia in experimental vein grafts.

Authors:  Thomas Schachner; Yping Zou; Alexander Oberhuber; Thomas Mairinger; Alexandar Tzankov; Günther Laufer; Harald Ott; Johannes Bonatti
Journal:  Eur J Cardiothorac Surg       Date:  2004-04       Impact factor: 4.191

10.  Neointimal Hyperplasia in Coronary Vein Grafts: Pathophysiology and Prevention of a Significant Clinical Problem.

Authors:  Johannes Bonatti; Alexander Oberhuber; Thomas Schachner; Yiping Zou; Angelika Hammerer-Lercher; Reinhard Mittermair; Guenther Laufer
Journal:  Heart Surg Forum       Date:  2004-01-01       Impact factor: 0.676

View more
  3 in total

1.  MicroRNA-26a targets MAPK6 to inhibit smooth muscle cell proliferation and vein graft neointimal hyperplasia.

Authors:  Juanjuan Tan; Liguo Yang; Cuicui Liu; Zhiqiang Yan
Journal:  Sci Rep       Date:  2017-04-21       Impact factor: 4.379

2.  COMPARATIVE STUDY OF MICROANASTOMOSIS WITH DISTINCT 10-0 NYLON SUTURES IN RATS.

Authors:  Ricardo Teixeira E Silva; Thiago Felipe Santos Barros; José Thomé de Carvalho; André Araújo Ribeiro; André Fernandes Pires; Teng Hsiang Wei
Journal:  Acta Ortop Bras       Date:  2016 Jan-Feb       Impact factor: 0.513

3.  Experimental study of histological changes in vascular loops according to the duration of the postoperative period: Application in reconstructive microsurgery.

Authors:  Renata Gregorio Paulos; Bruno Alves Rudelli; Renee Zon Filippe; Gustavo Bispo Dos Santos; Ana Abarca Herrera; Andre Araujo Ribeiro; Marcelo Rosa de Rezende; Teng Hsiang-Wei; Rames Mattar
Journal:  Clinics (Sao Paulo)       Date:  2017-10       Impact factor: 2.365

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.